|View printer-friendly version|
|March 01, 2007 1:28 p.m.|
|Teva Announces Approval of Alprazolam ER Tablets|
Jerusalem, Israel, March 1, 2007 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) for Alprazolam Extended Release Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. Shipment of this product will begin immediately.